Programma
08:30
Registration
09:00
Welcome
09:05
The Dutch DRUP study
Emile Voest, AvL, Amsterdam
09:35
Targeting KRAS: new hopes?
Egbert Smit, AvL, Amsterdam
10:00
Hopes and concerns in IO treatment
Solange Peters, CHUV, Lausanne
10:30
Break
11:00
Anti-angiogenesis: any future in 2020?
Francis Shepherd, Princess Margaret Cancer Centre, Toronto, Canada
11:30
NVALT 19
Sjaak Burgers, AvL, Amsterdam
11:50
How to treat the individual patient with target agents
12:30
Lunch
13:30
The cigarette: Addictive by Design
Jeffrey Wigand, Smoke-Free Kids Inc, Mount Pleasant, USA
14:00
Proton therapy in Lung Cancer
Hans Langendijk, UMCG, Groningen
DEBATE: Best strategy for oligometastatic disease
14:30
Oligometastatic disease introduction
Lizza Hendriks, Maastricht UMC+
14:50
Pro SBRT
M. Guckenberger, University of Würzburg, Germany
15:10
Pro surgery
John Edwards, Sheffield Teaching Hospital, United Kingdom
15:30
Voting and discussion
16:15
IAS studieprijs: Uitreiking Machiel van der Woude stipendium
Closing remarks and reception